Prelude Therapeutics Incorporated (PRLD) Earnings
NASDAQ·Healthcare·Biotechnology
$3.52
-2.22%
Mkt Cap $196.21M
EPS — Estimate vs Actual
Mkt Cap
$196.21M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58
NASDAQ·Healthcare·Biotechnology
$3.52
-2.22%
Mkt Cap $196.21M
Mkt Cap
$196.21M
P/E
—
Fwd P/E
—
P/S
20.15
Rev TTM
—
EPS TTM
-$1.58